Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Mayzent
Active Ingredient:	Siponimod fumarate 0.278mg equivalent to siponimod 0.25mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Novartis New Zealand Limited
Manufacturer:	Novartis Pharma Stein AG, Stein, Switzerland

*Product:*	Mayzent
Active Ingredient:	Siponimod fumarate 2.024mg equivalent to siponimod 2mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Novartis New Zealand Limited
Manufacturer:	Novartis Pharma Stein AG, Stein, Switzerland

Dated this 26th day of February 2021.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule